Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction

Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction

US Patent 10004811 · Granted Jun 26, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunod2025
Systems and methods for executing state machine in parallel with application cod2025
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glyc2025
Gene therapy for eosinophilic disorders2025
Treatment of brain cancers using central nervous system mediated gene transfer o2024
Treatment of brain cancers using central nervous system mediated gene transfer o2024
Treatment of brain cancers using central nervous system mediated gene transfer o2024
Oxidation-resistant AAT gene therapy2024
Oxidation-resistant AAT gene therapy2024
Oxidation-resistant AAT gene therapy2024
Oxidation-resistant AAT gene therapy2024
Treatment of brain cancers using central nervous system mediated gene transfer o2024